GSK-3117391

DB15440InvestigationalSmall molecule

GSK-3117391 is under investigation in clinical trial NCT02965599 (Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis).

Chemical structure of GSK-3117391
Formula / weight
C22H33N3O4 · 403.523 g/mol (avg)
Code names
GSK-3117391

Resolves to

Compound
UNIICKA3P0O1VICAS1018673-42-1
Structure
InChIKeyAFDPFLDWOXXHQM-NRFANRHFSA-NSMILESONC(=O)CCC1=NC=C(CN[C@@H](C2CCCCC2)C(=O)OC2CCCC2)C=C1

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of GSK-3117391, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In